Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 3/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3399464 | 0.95 | SLC6A4 (0.50) | SLC6A4ACHELMNAMAPK1 | |
| SCHEMBL30130487 | 0.95 | SLC6A4 (0.50) | SLC6A4ACHELMNAMAPK1 | |
| SCHEMBL20814673 | 0.90 | SLC6A4 (0.47) | SLC6A4ACHESLC6A9LMNAMAPK1 | |
| SCHEMBL20814664 | 0.88 | SLC6A4 (0.47) | SLC6A4ACHESLC6A9LMNAMAPK1 | |
| SCHEMBL3408176 | 0.88 | SLC6A4 (0.56) | SLC6A4ACHELMNAMAPK1 | |
| SCHEMBL30130509 | 0.88 | SLC6A4 (0.56) | SLC6A4ACHELMNAMAPK1 | |
| SCHEMBL21065413 | 0.87 | SLC6A4 (0.47) | SLC6A4ACHELMNAMAPK1 | |
| SCHEMBL468495 | 0.84 | SLC6A4 (0.52) | SLC6A4ACHELMNAMAPK1 | |
| SCHEMBL20814665 | 0.84 | SLC6A9 (0.45) | SLC6A4ACHESLC6A9LMNAMAPK1 | |
| SCHEMBL3407361 | 0.83 | ACHE (0.43) | SLC6A4ACHELMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3006023-B1 | SORBIC ACID AND DERIVATIVES THEREOF TO ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT (US) | 2019-06-26 | — | — | EP | disclosed |